On The Studies Show, we’re all about trying to get it right. But sometimes we get it wrong. Every so often, we’ll do a feedback/corrections/clarifications episode where we go back and try to correct any errors in the last few episodes, and reply to your more general feedback.
This is the first one of those, covering Episodes 1-8. Our thanks go to everyone who pointed out our mistakes. Please keep the feedback coming!
Show notes
* Retatrutide phase 2 trial; semaglutide vs. tirzepatide cost-effectiveness study
* The IARC’s useful, detailed report on (e.g.) whether being a firefighter is a cancer risk; the FDA disagrees with the IARC on whether aspartame should be labelled as a “possible” cause of cancer
* The newest published trial of psilocybin for depression
* Stuart’s more recent article on ultra-processed foods, with discussion of mechanisms; Chris Snowdon’s two part review of Chris van Tulleken’s book; interview with Herman Pontzer on his book Burn
Credits
The Studies Show is produced by Julian Mayers at Yada Yada Productions.
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.thestudiesshowpod.com/subscribe